Use of oral fluconazole during pregnancy and the risk of birth defects

New England Journal of Medicine

Volumn 369, Issue 9, 2013, Pages 830-839

  Mølgaard Nielsen, Ditte ^a   Pasternak, Björn ^a   Hviid, Anders ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ARTICLE; BIRTH DEFECT; CLEFT LIP; CLEFT PALATE; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; CRANIOFACIAL SYNOSTOSIS; DIAPHRAGM HERNIA; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG USE; FEMALE; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; LIMB DEFECT; LIMB REDUCTION DEFECT; LUNG HYPOPLASIA; MIDDLE EAR MALFORMATION; OUTCOME ASSESSMENT; POLYDACTYLY; PREGNANCY OUTCOME; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYNDACTYLY;

EID: 84883108965     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1301066     Document Type: Article

References (34)

1. Aleck KA, Bartley DL. Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient. Am J Med Genet 1997;72:253-6. (Pubitemid 27424225)
2. Lee BE, Feinberg M, Abraham JJ, Murthy AR. Congenital malformations in an infant born to a woman treated with fluconazole. Pediatr Infect Dis J 1992;11:1062-4.
3. Lopez-Rangel E, Van Allen MI. Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype. Birth Defects Res A Clin Mol Teratol 2005;73:919-23. (Pubitemid 41739255)
4. Pursley TJ, Blomquist IK, Abraham J, Andersen HF, Bartley JA. Fluconazole-induced congenital anomalies in three infants. Clin Infect Dis 1996;22:336-40. (Pubitemid 26056165)
5. Tiboni GM, Marotta F, Del Corso A, Giampietro F. Defining critical periods for itraconazole-induced cleft palate, limb defects and axial skeletal malformations in the mouse. Toxicol Lett 2006;167:8-18. (Pubitemid 44566438)
6. Mineshima H, Fukuta T, Kato E, et al. Malformation spectrum induced by ketoconazole after single administration to pregnant rats during the critical period - comparison with vitamin A-induced malformation spectrum. J Appl Toxicol 2012;32:98-107.
7. Tiboni GM, Giampietro F. Murine teratology of fluconazole: evaluation of developmental phase specificity and dose dependence. Pediatr Res 2005;58:94-9. (Pubitemid 40967436)
8. Food and Drug Administration. Use of long-term, high-dose Diflucan (fluconazole) during pregnancy may be associated with birth defects in infants. 2011 (http://www.fda.gov/Drugs/DrugSafety/ucm266030.htm).
9. Marotta F, Tiboni GM. Molecular aspects of azoles-induced teratogenesis. Expert Opin Drug Metab Toxicol 2010;6:461-82.
10. Inman W, Pearce G, Wilton L. Safety of fluconazole in the treatment of vaginal candidiasis: a prescription-event monitoring study, with special reference to the outcome of pregnancy. Eur J Clin Pharmacol 1994;46:115-8. (Pubitemid 24101326)
11. Jick SS. Pregnancy outcomes after maternal exposure to fluconazole. Pharmacotherapy 1999;19:221-2. (Pubitemid 29072033)
12. Mastroiacovo P, Mazzone T, Botto LD, et al. Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole. Am J Obstet Gynecol 1996;175:1645-50. (Pubitemid 27021041)
13. Nørgaard M, Pedersen L, Gislum M, et al. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study. J Antimicrob Chemother 2008;62:172-6. (Pubitemid 351865893)
14. Wilton LV, Pearce GL, Martin RM, Mackay FJ, Mann RD. The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. Br J Obstet Gynaecol 1998;105:882-9. (Pubitemid 28423505)
15. Carter TC, Druschel CM, Romitti PA, Bell EM, Werler MM, Mitchell AA. Antifungal drugs and the risk of selected birth defects. Am J Obstet Gynecol 2008;198(2):191.e1-191.e7.
16. Sobel JD. Vulvovaginal candidosis. Lancet 2007;369:1961-71. (Pubitemid 46874580)
17. Eckert LO. Acute vulvovaginitis. N Engl J Med 2006;355:1244-52. [Erratum, N Engl J Med 2006;355:2797.] (Pubitemid 44427448)
18. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull 1998;45:320-3. (Pubitemid 28313542)
19. Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health 2011;39: Suppl:38-41.
20. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011;39:Suppl:30-3.
21. Pedersen CB. The Danish Civil Registration System. Scand J Public Health 2011;39:Suppl:22-5.
22. Jørgensen FS. Ultrasonography of pregnant women in Denmark 1999-2000: description of the development since 1980-1990. Ugeskr Laeger 2003;165:4409-15. (In Danish.) (Pubitemid 38113469)
23. Briggs GG, Freeman RK, Yaffe SJ. Itraconazole. In: Shaw R, ed. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2008:994-6.
24. Kazy Z, Puhó E, Czeizel AE. The possible association between the combination of vaginal metronidazole and miconazole treatment and poly-syndactyly: population-based case-control teratologic study. Reprod Toxicol 2005;20:89-94. (Pubitemid 40459656)
25. Idem. Population-based case-control study of oral ketoconazole treatment for birth outcomes. Congenit Anom (Kyoto) 2005;45:5-8.
26. Coding and classification. In: EUROCAT guide 1.3 and reference documents: instructions for the registration and surveillance of congenital anomalies. Ulster, United Kingdom: EUROCAT, 2012.
27. Clayton D, Hills M. Poisson and logistic regression. In: Clayton D, Hills M, eds. Statistical models in epidemiology. Oxford, England: Oxford University Press, 2001:227-36.
28. Nilas L, Hansen BL. Candidat vaginit, 2012 (https://www.sundhed.dk/ sundhedsfaglig/laegehaandbogen/gynaekologi/tilstande-og-sygdomme/infektioner/ candida-vaginit/).
29. Jenkins KJ, Correa A, Feinstein JA, et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007;115:2995-3014. (Pubitemid 46912106)
30. Bar-Oz B, Moretti ME, Bishai R, et al. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study. Am J Obstet Gynecol 2000;183:617-20.
31. Agergaard P, Hebert A, Bjerre J, Sørensen KM, Olesen C, Ostergaard JR. Children diagnosed with congenital cardiac malformations at the national university departments of pediatric cardiology: positive predictive values of data in the Danish National Patient Registry. Clin Epidemiol 2011;3:61-6. [Erratum, Clin Epidemiol 2011;3:131.]
32. Larsen H, Nielsen GL, Bendsen J, Flint C, Olsen J, Sørensen HT. Predictive value and completeness of the registration of congenital abnormalities in three Danish population-based registries. Scand J Public Health 2003;31:12-6. (Pubitemid 40990826)
33. Daneshmend TK. Systemic absorption of miconazole from the vagina. J Antimicrob Chemother 1986;18:507-11. (Pubitemid 16030729)
34. Ritter W, Patzschke K, Krause U, Stettendorf S. Pharmacokinetic fundamentals of vaginal treatment with clotrimazole. Chemotherapy 1982;28:Suppl 1:37-42. (Pubitemid 13224546)